COVID Collaborative and partners launched on September 7, 2022, the COVID Treatment Quick Start Consortium to bring new, highly effective COVID-19 oral antiviral treatments to high-risk populations in 10 low- and middle-income countries. Quick Start includes COVID Collaborative, Duke University, the Clinton Health Access Initiative, and Americares as implementing partners, with support from the Open Society Foundations, the Conrad N. Hilton Foundation, and Pfizer. Partner countries include Ghana, Kenya, Laos, Malawi, Nigeria, Rwanda, South Africa, Uganda, Zambia, and Zimbabwe.